148 related articles for article (PubMed ID: 29923183)
1. "Faggot" neutrophils in acute promyelocytic leukaemia with ongoing tretinoin therapy.
Ma S; Yang LH; Luedke C; Ingersoll K; Wang E
Br J Haematol; 2018 Oct; 183(2):169. PubMed ID: 29923183
[No Abstract] [Full Text] [Related]
2. Mature neutrophils with Auer rods following treatment with all-trans retinoic acid for acute promyelocytic leukemia.
Luu HS; Rahaman PA
Blood; 2015 Jul; 126(1):121. PubMed ID: 26347920
[No Abstract] [Full Text] [Related]
3. Reactive oxygen species production of neutrophils in patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid.
Ohno E; Ohtsuka E; Saburi Y; Ono K; Kikuchi H; Nasu M
Am J Hematol; 1999 Oct; 62(2):120-1. PubMed ID: 10577282
[TBL] [Abstract][Full Text] [Related]
4. Tretinoin in the treatment of acute promyelocytic leukemia.
Wong WM
Cancer Pract; 1996; 4(4):220-3. PubMed ID: 8900766
[No Abstract] [Full Text] [Related]
5. All-trans retinoic acid and hematopoietic growth factors regulating the growth and differentiation of blast progenitors in acute promyelocytic leukemia.
Miyauchi J
Leuk Lymphoma; 1999 Apr; 33(3-4):267-80. PubMed ID: 10221506
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid and arsenic for treating acute promyelocytic leukemia.
Zhou GB; Zhao WL; Wang ZY; Chen SJ; Chen Z
PLoS Med; 2005 Jan; 2(1):e12. PubMed ID: 15696202
[TBL] [Abstract][Full Text] [Related]
7. All-trans-retinoic acid induced enrichment of functionally normal neutrophils in vivo in a patient with acute promyelocytic leukemia.
Itoh Y; Ohyashiki K; Ohtaka M; Furuya T; Toyama K; Kuratsuji T; Ohno R
Leukemia; 1992 Aug; 6(8):806-8. PubMed ID: 1640732
[TBL] [Abstract][Full Text] [Related]
8. Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.
Gillis JC; Goa KL
Drugs; 1995 Nov; 50(5):897-923. PubMed ID: 8586032
[TBL] [Abstract][Full Text] [Related]
9. Development and overcoming of ATRA resistance in acute promyelocytic leukemia.
Lo Coco F
Haematologica; 1999 Nov; 84(11):961-2. PubMed ID: 10553153
[No Abstract] [Full Text] [Related]
10. [Disseminated intravascular coagulation in malignant neoplasms].
Kato A
Rinsho Ketsueki; 2010 Jan; 51(1):37-43. PubMed ID: 20134138
[No Abstract] [Full Text] [Related]
11. [Lessons learned from differentiation therapy with all-trans retinoic acid in the JALSG APL studies].
Asou N
Rinsho Ketsueki; 2004 Feb; 45(2):115-24. PubMed ID: 15045819
[No Abstract] [Full Text] [Related]
12. [All-trans retinoic acid therapy in acute promyelocytic leukemia--current status and prospect].
Kitamura K; Takeshita A; Ono R; Naoe T
Rinsho Ketsueki; 1996 Sep; 37(9):760-5. PubMed ID: 8914458
[No Abstract] [Full Text] [Related]
13. Treatment of acute myeloid leukemia M3 in a patient with Crohn's disease.
Harewood G; Markovic S
Cancer Invest; 2000; 18(1):98. PubMed ID: 10701373
[No Abstract] [Full Text] [Related]
14. The maturation of differentiation therapy.
Cheson BD
N Engl J Med; 1992 Aug; 327(6):422-4. PubMed ID: 1625719
[No Abstract] [Full Text] [Related]
15. TRAIL leads to apoptosis in acute promyelocytic leukaemia.
Bradbury J
Lancet; 2001 Jun; 357(9270):1770. PubMed ID: 11403822
[No Abstract] [Full Text] [Related]
16. Auer rods and differentiation in acute promyelocytic leukemia.
Zassadowski F; Ades L; Schlageter MH; Chevret S; Guillemot I; Fenaux P; Chomienne C; Cassinat B
Br J Haematol; 2008 Sep; 142(6):998-1000. PubMed ID: 18544082
[No Abstract] [Full Text] [Related]
17. [Arsenic trioxide, a new drug for the treatment of acute promyelocytic leukemia resistant to tretinoine].
Haanen C; Vermes I
Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1738-41. PubMed ID: 10494320
[TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukemia--weapons of mass differentiation.
Licht JD
N Engl J Med; 2009 Feb; 360(9):928-30. PubMed ID: 19246367
[No Abstract] [Full Text] [Related]
19. Reduced plasma all-trans retinoic acid level in a patient with Crohn's disease with acute promyelocytic leukemia.
Takitani K; Inoue A; Kawakami C; Miyazaki H; Aomatsu T; Yoden A; Suzuki K; Tamai H
Leuk Lymphoma; 2009 Feb; 50(2):300-2. PubMed ID: 19160127
[No Abstract] [Full Text] [Related]
20. [Treatment of malignant hemopathies with all transretinoic acid].
Fenaux P; Chomienne C
Presse Med; 1997 Oct; 26(29):1399-405. PubMed ID: 9404351
[No Abstract] [Full Text] [Related]
[Next] [New Search]
